مقالات در نشریات
- 1. Yadegari, F., Farahmand, L., Esmaeili, R., Zarinfam, S., Majidzadeh ,& A, K.,Inter-BRCT linker is probably the most intolerant region of the BRCA1 BRCT domain,Journal of Biomolecular Structure and Dynamics,2024.
- 2. Khodaverdi, E., Shabani, A.A., Madanchi, H., Farahmand, L.,Synthesis of the scFv fragment of anti-Frizzled-7 antibody and evaluation of its effects on triple-negative breast cancer in vitro study,Clinical and Translational Oncology,2024.
- 3. Shokrollahi Barough, M., Jalili, N., Shafiee, S., (...), Hosseinzadeh, A., Farahmand, L.,Anti-MUC1 nanobody can synergize the Tamoxifen and Herceptin effects on breast cancer cells by inducing ER, PR and HER2 overexpression,International Immunopharmacology,2023.
- 4. Mirzaei, R., Shafiee, S., Vafaei, R., (...), Reza Esmailinejad, M., Farahmand, L.,Production of novel recombinant anti-EpCAM antibody as targeted therapy for breast cancer,International Immunopharmacology,2023.
- 5. Shafiee, S., Mirzaei, R., Salehi, M., (...), Taheri, A., Farahmand, L.,Synthesized Anti-HER2 Trastuzumab-MCC-DM1 Conjugate: An Evaluation of Efficacy and Cytotoxicity,Iranian Journal of Immunology,2023.
- 6. Vafaei, R., Khaki, Z., Salehi, M., (...), Mirzaei, R., Farahmand, L.,Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer,Investigational New Drugs,2023.
- 7. Khodabakhsh, F., Shokri, S., Jalili, N., (...), Dashtestani, F., Farahmand, L.,Anti-MUC1 nanobody conjugated by chitosan nanoparticle with enhancement of anti-proliferation activity in breast cancer cell lines,Chemical Papers,2023.
- 8. Ahani, M., Salarian, M., Salehi, M., (...), Taheri, A., Farahmand, L.,Synthesis of Succinimidyl 4-(N-maleimidomethyl)-Cyclohexane-1-Carboxylate (SMCC) as a Linker and Conjugating Trastuzumab to Maytansinoid Derivative (DM1) Through SMCC as an Antibody-Drug Conjugate,Pharmaceutical Chemistry Journal,,2023.
- 9. Merikhian, P., Darvishi, B., Jalili, N., (...), Rahbarizadeh, F., Farahmand, L.,Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors,Molecular Oncology,2022.
- 10. Vafaei, R., Samadi, M., Hosseinzadeh, A., (...), Khaki, Z., Farahmand, L.,Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study,Cancer Cell International,2022.
- 11. Samadi, M., Beigi, L., Yadegari, F., (...), Eskordi, M., Farahmand, L.,Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants,Genetica,2022.
- 12. Barzaman, K., Vafaei, R., Samadi, M., (...), Dinvari, H., Farahmand, L.,Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk,Cancer Cell International,2022.
- 13. Hosseinzadeh, A., Merikhian, P., Naseri, N., Eisavand, M.R., Farahmand, L.,MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy,Cancer Cell International,2022.
- 14. Ashrafian, S., Zarrineh, M., Jensen, P., (...), Ghassempour, A., Larsen, M.R.,Quantitative Phosphoproteomics and Acetylomics of Safranal Anticancer Effects in Triple-Negative Breast Cancer Cells,Journal of Proteome Research,2022.
- 15. Darvishi, B., Eisavand, M.R., Majidzadeh ,& A, K., Farahmand, L.,Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance,British Journal of Cancer,2022.
- 16. Akhlaghi, M., Taebpour, M., Lotfabadi, N.N., (...), Rahmanian, M., Tofighi, D.,Synthesis and characterization of smart stimuli-responsive herbal drug-encapsulated nanoniosome particles for efficient treatment of breast cancer,Nanotechnology Reviews,2022.
- 17. Samadi, M., Majidzadeh , A, K., Salehi, M., (...), Moradi , Kalbolandi, S., Farahmand, L.,Correction: Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo (Journal of Biological Engineering,Journal of Biological Engineering,2022.
- 18. Majidzadeh ,& A, K., Zarinfam, S., Abdoli, N., (...), Salehi, M., Zamani, M.,A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel,Familial Cancer,2022.
- 19. Barati, M., Javidi, M.A., Darvishi, B., (...), Farahmand, L., Madjid Ansari, A.,Necroptosis triggered by ROS accumulation and Ca2+ overload, partly explains the inflammatory responses and anti-cancer effects associated with 1Hz, 100 mT ELF-MF in vivo,Free Radical Biology and Medicine,2021.
- 20. Haji Abdolvahab, M., Moradi , kalbolandi, S., Zarei, M., (...), Majidzadeh , A, K., Farahmand, L.,Potential role of interferons in treating COVID-19 patients,International Immunopharmacology,2021.
نمایش ۱ تا ۲۰ مورد از کل ۷۵ مورد.